VanEck's TDIV ETF nears 52-week high as earnings season, ECB rate decision, and US GDP data loom. Top holdings like Verizon and Roche report, with financials and energy in focus.

Nestlé confirms Blue Bottle Coffee sale for under $400M, half its 2017 price, as Q1 organic sales growth of 3.5% beats ...

The stars are not aligning for Barrick Mining. While the Canadian gold giant posted a near-$5 billion profit last year and ...

The investment case for hydrogen has long been framed around decarbonisation. That story is being rewritten. Rising ...

German defence sensor maker Hensoldt sees orders surge 62% but shares near 52-week lows amid Chinese export restrictions and capacity expansion costs.

BioNTech's personalized mRNA cancer vaccine posts striking 6-year survival data in pancreatic cancer, while its CureVac subsidiary files a new patent lawsuit against Moderna.

ServiceNow shares rebound after 18% rout, driven by strong Q1 revenue and AI traction, but Armis acquisition margins and 39% ...

Oracle's $553B backlog and 84% cloud growth clash with $124.7B debt and negative cash flow, as stock trades 48% below its ...

Rheinmetall shares hit a fresh 52-week low despite billion-euro contracts and strong growth targets. Key catalysts in May ...

ASX suspends European Lithium shares at A$0.285 after media reports of a potential change of control, with the Wolfsberg lithium project in Austria at the center of the story.

The week leading up to The Trade Desk’s first-quarter earnings release on May 7 has become a crucible for the ad-tech company, where a groundbreaking product la ...

Novo Nordisk shares jump 6.66% as EU eases Wegovy transport rules, but US Medicare price cuts and a lobbying pivot signal ...